Betaine in wine: Answer to the French paradox?

Medical Hypotheses

Volumn 53, Issue 5, 1999, Pages 383-385

  Mar, Mei Heng ^a   Zeisel, S H ^a  

^a University of North Carolina at Chapel Hill   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BETAINE; CHOLESTEROL; HOMOCYSTEINE; SATURATED FATTY ACID; SUCROSE;

ALCOHOL CONSUMPTION; AMINO ACID METABOLISM; ARTICLE; CEREBROVASCULAR DISEASE; DIET; FRANCE; HYPERHOMOCYSTEINEMIA; ISCHEMIC HEART DISEASE; METHYLATION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RISK FACTOR; WINE;

BETA VULGARIS SUBSP. VULGARIS;

EID: 0032703193     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1054/mehy.1998.0791     Document Type: Article

References (29)

1. Hennekens C., Willett W., Rosner B., Cole D., Mayrent S. Effects of beer, wine, and liquor in coronary deaths. J Am Med Assoc. 242:1979;1973-1974.
2. Klatsky A., Armstrong M., Friedman G. Red wine, white wine, liquor, beer, and risk for coronary artery disease hospitalization. Am J Cardiol. 80:1997;416-420.
3. Renaud S., de Lorgeril M. 1992 Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet. 339:1992;1523-1526.
4. Sharp D. 1993 Coronary disease. When wine is red. Lancet. 341:1993;27-28.
5. Crique M., Ringel B. 1994 Does diet or alcohol explain the French paradox. Lancet. 344:1994;1719-1723.
6. Frankel E. N., Kanner J., German J. B., Parks E., Kinsella J. E. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet. 341:1993;454-457.
7. Constant J. Alcohol, ischemic heart disease, and the French paradox. Clin Cardiol. 20:1997;420-424.
8. Parodi P. The French paradox unmasked: the role of folate. Med Hypotheses. 49:1997;313-318.
9. McCully K. 1996 Homocysteine and vascular disease. Nat Med. 2:1996;386-389.
10. Malinow M. 1996 Plasma homocyst(e)ine: a risk factor for arterial occlusive diseases. J Nutr. 126:1996;1238S-1243S.
11. Verhoef P., Hennekens C., Allen R., Stabler S., Willett W., Stampfer M. Plasma total homocysteine and risk of angina pectoris with subsequent coronary artery bypass surgery. Am J Cardiol. 79:1997;799-801.
12. Verhoef P., Stampfer M. Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate. Am J Epidemiol. 143:1996;845-859.
13. van den Berg M., Stehouwer C., Bierdrager E., Rauwerda J. Plasma homocysteine and severity of atherosclerosis in young patients with lower-limb atherosclerotic disease. Arterioscler Thromb Vasc Biol. 16:1996;165-171.
14. Ubbink J., Vermaak W., Delport R., van der Merwe A., Becker P., Potgieter H. Effective homocysteine metabolism may protect South African blacks against coronary heart disease. Am J Clin Nutr. 62:1995;802-808.
15. Glueck C. J., Shaw P., Lang J. E., Tracy T., Sieve-Smith L., Wang Y. Evidence that homocysteine is an independent risk factor for atherosclerosis in hyperlipidemic patients. Am J Cardiol. 75:1995;132-136.
16. Boushey C., Beresford S., Omenn G., Motulsky A. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable bene1/2ts of increasing folic acid intakes. J Am Med Assoc. 274:1995;1049-1057.
17. Wendel U., Bremer H. Betaine in the treatment of homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency. Eur J Pediatr. 142:1984;147-150.
18. Dudman N., Guo X., Gordon R., Dawson P., Wilcken D. Human homocysteine catabolism: three major pathways and their relevance to development of arterial occlusive disease. J Nutr. 126:1996;1295S-1300S.
19. Med Lett Drug Ther. 39:1997;12.
20. Wilcken D., Dudman N., Tyrrell P. Homocystinuria due to cystathionine b-synthase de1/2ciency - the effects of betaine treatment in pyridoxine-responsive patients. Metabolism. 34:1985;1115-1121.
21. Sunden S., Renduchintala M., Park E., Miklasz S., Garrow T. Betaine-homocysteine methyltransferase expression in porcine and human tissues and chromosomal localization of the human gene. Arch Biochem Biophys. 345:1997;171-174.
22. Malinow M. R. Plasma homocyst(e)ine and arterial occlusive diseases: a mini-review. Clin Chem. 41:1995;173-176.
23. Finkelstein J. D., Kyle W. E., Harris B. J. Methionine metabolism in Mammals. Regulation of homocysteine methyltransferase in rat tissue. Arch Biochem Biophys. 146:1971;84-92.
24. Finkelstein J. D., Harris B. J., Kyle W. E. Methionine metabolism in mammals: kinetic study of betaine-homocysteine methyltransferase. Arch Biochem Biophys. 153:1972;320-324.
25. Finkelstein J. D., Martin J. J. Methionine metabolism in mammals. Distribution of homocysteine between competing pathways. J Biol Chem. 259:1984;9508-9513.
26. Dupuy P. Analytical evidences of sugar added to wine. Ann Nutr Aliment. 32:1978;1123-1132.
27. Mar M. H., Ridky T. W., Garner S. C., Zeisel S. H. A method for the determination of betaine in tissues using high performance liquid chromatography. J Nutr Biochem. 6:1995;392-398.
28. Varela-Moreiras G., Ragel C., Perez de Miguelsanz J. Choline deficiency and methotrexate treatment induces marked but reversible changes in hepatic folate concentrations, serum homocysteine and DNA methylation rates in rats. J Am Coll Nutr. 14:1995;480-485.
29. Zeisel S. H., Blusztajn J. K. Choline and human nutrition. Ann Rev Nutr. 14:1994;269-296.